Article Information
History
- September 10, 2020.
Article Versions
- You are currently viewing Version 1 of this article (September 10, 2020 - 03:27).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Christos Fotis1,*,
- Nikolaos Meimetis1,*,
- Nikos Tsolakos2,*,
- Marianna Politou3,*,
- Karolina Akinosoglou4,*,
- Vicky Pliaka2,
- Angeliki Minia2,
- Evangelos Terpos3,
- Ioannis P. Trougakos5,
- Andreas Mentis6,
- Markos Marangos4,
- George Panayiotakopoulos7,8,
- Meletios A. Dimopoulos3,
- Charalampos Gogos4,
- Alexandros Spyridonidis9,$,# and
- Leonidas G. Alexopoulos1,2,$,#
- 1Biomedical Systems Laboratory, National Technical University of Athens, Athens, Greece
- 2ProtATonce Ltd, Demokritos Science Park, Athens, Greece
- 3Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece
- 4Department of Internal Medicine, Division of Infectious Diseases, University Hospital of Patras, Patras, Greece
- 5Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
- 6Medicinal Microbiology Laboratory, Hellenic Pasteur Institute, Athens, Greece
- 7Pharmacology Laboratory, University of Patras, Patras, Greece
- 8National Public Health Organization, Athens, Greece
- 9Department of Internal Medicine, BMT Unit and CBMDP Donor Center, University of Patras, Patras, Greece
- ↵$Correspondence: E-mails: leo{at}mail.ntua.gr (LGA) and spyridonidis{at}upatras.gr (AS)
Posted September 10, 2020.
Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach
